Fig. 1 · Structure
Documents & Downloads
Pirifibrate
Hypolipemic Agent
Pirifibrate is a hypolipemic agent that primarily targets lipid metabolism pathways. It is effective in reducing elevated levels of lipoproteins, making it useful for research into hyperlipoproteinemias and related dyslipidemias. This compound may facilitate studies aimed at understanding lipid regulation and potential therapeutic approaches for cardiovascular diseases associated with lipid abnormalities.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 55285-45-5 |
| Applications | Hypolipemic Agent |
| Formula | C17H18ClNO4 |
| Molecular Weight | 335.78 |
| Synonyms | EL-466 |
| SMILES | O=C(C(C)(C)OC1=CC=C(C=C1)Cl)OCC2=NC(CO)=CC=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.